Clinical Trials Directory

Trials / Completed

CompletedNCT06303557

Effect of ESPB on Intraoperative Remifentanil Consumption

Effect of ESPB on Intraoperative Remifentanil Consumption in Lumbar Spine Surgery

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Atatürk Chest Diseases and Chest Surgery Training and Research Hospital · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

In recent years, regional anesthesia techniques have also been frequently applied to patients for pain relief. Erector spinae plane block (ESPB), is among the regional anesthesia techniques frequently used in lumbar spine surgery. General anesthesia (GA) is the main method of anesthesia for lumbar spine surgery. However, GA can only inhibit the projection system of the cortical limbic system or hypothalamic cortex. GA cannot completely block the transmission of peripheral noxious stimulus to the central nervous system and cannot effectively inhibit the intraoperative stress response. With the addition of peripheral blocks such as ESPB, lower remifentanil consumption, and more stable hemodynamics are expected by providing preemptive analgesia in patients. As a result of all these; it was aimed to compare the intraoperative remifentanil consumption of patients who underwent preoperative ESPB in patients who will undergo lumbar spine surgery resection under GA with those who underwent postoperative ESPB.

Conditions

Interventions

TypeNameDescription
DRUGPreoperative Erector Spinae Plane BlockErector spinae plane block will be performed bilaterally, under US guidance, before the surgical operation, after the induction of anesthesia, and when the patient is placed in the prone position.
DRUGPostoperative Erector Spinae Plane BlockErector spinae plane block will be performed unilaterally, under US guidance, after the surgical operation, under general anesthesia, and when the patient is placed in the prone position.

Timeline

Start date
2024-01-31
Primary completion
2025-11-03
Completion
2025-11-13
First posted
2024-03-12
Last updated
2025-11-26

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06303557. Inclusion in this directory is not an endorsement.